414 related articles for article (PubMed ID: 34056740)
21. Parkinson's Disease and Ischemic Stroke: a Bidirectional Mendelian Randomization Study.
Fang S; Hu X; Wang T; Yang Y; Xu R; Zhang X; Luo J; Ma Y; Patel AB; Dmytriw AA; Jiao L
Transl Stroke Res; 2022 Aug; 13(4):528-532. PubMed ID: 35013977
[TBL] [Abstract][Full Text] [Related]
22. No Evidence for a Causal Relationship Between Cancers and Parkinson's Disease.
Senkevich K; Bandres-Ciga S; Yu E; Liyanage UE; ; Noyce AJ; Gan-Or Z
J Parkinsons Dis; 2021; 11(2):801-809. PubMed ID: 33646179
[TBL] [Abstract][Full Text] [Related]
23. Increased Menopausal Age Reduces the Risk of Parkinson's Disease: A Mendelian Randomization Approach.
Kusters CDJ; Paul KC; Duarte Folle A; Keener AM; Bronstein JM; Bertram L; Hansen J; Horvath S; Sinsheimer JS; Lill CM; Ritz BR
Mov Disord; 2021 Oct; 36(10):2264-2272. PubMed ID: 34426982
[TBL] [Abstract][Full Text] [Related]
24. Mendelian Randomization Study Using Dopaminergic Neuron-Specific eQTL Nominates Potential Causal Genes for Parkinson's Disease.
Dang X; Zhang Z; Luo XJ
Mov Disord; 2022 Dec; 37(12):2451-2456. PubMed ID: 36177513
[TBL] [Abstract][Full Text] [Related]
25. Plasma urate concentration and risk of coronary heart disease: a Mendelian randomisation analysis.
White J; Sofat R; Hemani G; Shah T; Engmann J; Dale C; Shah S; Kruger FA; Giambartolomei C; Swerdlow DI; Palmer T; McLachlan S; Langenberg C; Zabaneh D; Lovering R; Cavadino A; Jefferis B; Finan C; Wong A; Amuzu A; Ong K; Gaunt TR; Warren H; Davies TL; Drenos F; Cooper J; Ebrahim S; Lawlor DA; Talmud PJ; Humphries SE; Power C; Hypponen E; Richards M; Hardy R; Kuh D; Wareham N; Ben-Shlomo Y; Day IN; Whincup P; Morris R; Strachan MW; Price J; Kumari M; Kivimaki M; Plagnol V; Whittaker JC; ; Smith GD; Dudbridge F; Casas JP; Holmes MV; Hingorani AD;
Lancet Diabetes Endocrinol; 2016 Apr; 4(4):327-36. PubMed ID: 26781229
[TBL] [Abstract][Full Text] [Related]
26. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: A phenome-wide mendelian randomization study.
Li X; Meng X; He Y; Spiliopoulou A; Timofeeva M; Wei WQ; Gifford A; Yang T; Varley T; Tzoulaki I; Joshi P; Denny JC; Mckeigue P; Campbell H; Theodoratou E
PLoS Med; 2019 Oct; 16(10):e1002937. PubMed ID: 31626644
[TBL] [Abstract][Full Text] [Related]
27. Investigating the Shared Genetic Etiology Between Parkinson's Disease and Depression.
Reyes-Pérez P; García-Marín LM; Aman AM; Antar T; Flores-Ocampo V; Mitchell BL; Medina-Rivera A; Rentería ME
J Parkinsons Dis; 2024; 14(3):483-493. PubMed ID: 38457145
[TBL] [Abstract][Full Text] [Related]
28. Assessment of causal factors for Parkinson's disease in European populations: A phenome-wide Mendelian randomisation analysis.
Xue Z; Cheng Y; Yu Q; Wang T; Fan C; Zou Z; Zhang X
Asia Pac J Clin Nutr; 2021 Jun; 30(2):329-339. PubMed ID: 34191436
[TBL] [Abstract][Full Text] [Related]
29. Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization study.
Domínguez-Baleón C; Ong JS; Scherzer CR; Rentería ME; Dong X
Sci Rep; 2021 Jul; 11(1):13980. PubMed ID: 34234189
[TBL] [Abstract][Full Text] [Related]
30. Genetically predicted serum urate levels have no causal role on depression or other psychiatric disorders.
Zhao SS; Qian Y; Mackie SL; Wen C; Mao Y
Clin Rheumatol; 2021 Sep; 40(9):3729-3733. PubMed ID: 33786690
[TBL] [Abstract][Full Text] [Related]
31. Psoriasis and progression of Parkinson's disease: a Mendelian randomization study.
Li C; Li X; Lin J; Cui Y; Shang H
J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):2401-2405. PubMed ID: 35870136
[TBL] [Abstract][Full Text] [Related]
32. Dairy Intake and Parkinson's Disease: A Mendelian Randomization Study.
Domenighetti C; Sugier PE; Ashok Kumar Sreelatha A; Schulte C; Grover S; Mohamed O; Portugal B; May P; Bobbili DR; Radivojkov-Blagojevic M; Lichtner P; Singleton AB; Hernandez DG; Edsall C; Mellick GD; Zimprich A; Pirker W; Rogaeva E; Lang AE; Koks S; Taba P; Lesage S; Brice A; Corvol JC; Chartier-Harlin MC; Mutez E; Brockmann K; Deutschländer AB; Hadjigeorgiou GM; Dardiotis E; Stefanis L; Simitsi AM; Valente EM; Petrucci S; Duga S; Straniero L; Zecchinelli A; Pezzoli G; Brighina L; Ferrarese C; Annesi G; Quattrone A; Gagliardi M; Matsuo H; Kawamura Y; Hattori N; Nishioka K; Chung SJ; Kim YJ; Kolber P; van de Warrenburg BPC; Bloem BR; Aasly J; Toft M; Pihlstrøm L; Correia Guedes L; Ferreira JJ; Bardien S; Carr J; Tolosa E; Ezquerra M; Pastor P; Diez-Fairen M; Wirdefeldt K; Pedersen NL; Ran C; Belin AC; Puschmann A; Hellberg C; Clarke CE; Morrison KE; Tan M; Krainc D; Burbulla LF; Farrer MJ; Krüger R; Gasser T; Sharma M; Elbaz A;
Mov Disord; 2022 Apr; 37(4):857-864. PubMed ID: 34997937
[TBL] [Abstract][Full Text] [Related]
33. Sleep behaviors and Parkinson's disease: A bidirectional Mendelian randomization analysis.
Ling Y; Zhu J; Yan F; Tse LA; Kinra S; Jiang M
Behav Brain Res; 2023 Mar; 441():114281. PubMed ID: 36608706
[TBL] [Abstract][Full Text] [Related]
34. The Parkinson's Disease Genome-Wide Association Study Locus Browser.
Grenn FP; Kim JJ; Makarious MB; Iwaki H; Illarionova A; Brolin K; Kluss JH; Schumacher-Schuh AF; Leonard H; Faghri F; Billingsley K; Krohn L; Hall A; Diez-Fairen M; Periñán MT; Foo JN; Sandor C; Webber C; Fiske BK; Gibbs JR; Nalls MA; Singleton AB; Bandres-Ciga S; Reed X; Blauwendraat C;
Mov Disord; 2020 Nov; 35(11):2056-2067. PubMed ID: 32864809
[TBL] [Abstract][Full Text] [Related]
35. Unbiased metabolome screen links serum urate to risk of Alzheimer's disease.
Şanlı BA; Whittaker KJ; Motsi GK; Shen E; Julian TH; Cooper-Knock J
Neurobiol Aging; 2022 Dec; 120():167-176. PubMed ID: 36206691
[TBL] [Abstract][Full Text] [Related]
36. Genetic Modifiers of Age at Onset for Parkinson's Disease in Asians: A Genome-Wide Association Study.
Li C; Ou R; Chen Y; Gu X; Wei Q; Cao B; Zhang L; Hou Y; Liu K; Chen X; Song W; Zhao B; Wu Y; Li T; Dong X; Shang H
Mov Disord; 2021 Sep; 36(9):2077-2084. PubMed ID: 33884653
[TBL] [Abstract][Full Text] [Related]
37. Plasma Caffeine Levels and Risk of Alzheimer's Disease and Parkinson's Disease: Mendelian Randomization Study.
Larsson SC; Woolf B; Gill D
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565667
[TBL] [Abstract][Full Text] [Related]
38. Visceral adipose tissue had a causal, independent role in lowering the risk of Parkinson's disease: A mendelian randomization study.
Liu Y; Liu Q
Parkinsonism Relat Disord; 2021 Nov; 92():51-52. PubMed ID: 34695655
[TBL] [Abstract][Full Text] [Related]
39. Mendelian Randomization - the Key to Understanding Aspects of Parkinson's Disease Causation?
Noyce AJ; Nalls MA
Mov Disord; 2016 Apr; 31(4):478-83. PubMed ID: 26695521
[TBL] [Abstract][Full Text] [Related]
40. Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome.
Storm CS; Kia DA; Almramhi MM; Bandres-Ciga S; Finan C; ; Hingorani AD; Wood NW
Nat Commun; 2021 Dec; 12(1):7342. PubMed ID: 34930919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
